Department of Gynecological Oncology, Metaxa Memorial Cancer Hospital, Piraeus, Greece.
Department of Surgical Oncology, Metaxa Memorial Anticancer Hospital, Mpotasi 51, Piraeus, Greece.
Arch Gynecol Obstet. 2019 Jul;300(1):25-31. doi: 10.1007/s00404-019-05176-y. Epub 2019 May 6.
Cervical cancer (CC) ranks 2nd for mortality among women of reproductive age in the United States. Abdominal radical trachelectomy (ART) is a fertility sparing approach that has been proposed in women with early stage CC who wish to preserve their fertility. The aim of the present meta-analysis was to evaluate the short- and long-term outcomes of RH vs ART for early stage CC.
A total of 5 electronic databases were searched for articles published up to December 2018. Prospective and retrospective trials reporting outcomes for women who underwent ART or RH for the management of early stages CC, were considered eligible for inclusion. Statistical meta-analysis was performed using the RevMan 5.3 software.
A total of 5 studies which included 840 women who underwent ART or radical trachelectomy (RH) were included in the present meta-analysis. Among them, 324 underwent ART whereas the remaining 516 had RH. Despite the fact that ART was associated with significantly prolonged operative time compared to RH (840 patients MD 36.82 min, 95% CI 20.15-53.49, p < 0.001), neither 5-year OS nor 5-year DFS were different among the two groups (714 patients OR 1.39, 95% CI 0.53-3.62, p = 0.51 and 682 patients OR 1.08, 95% CI 0.52-2.25, p = 0.84, respectively).
ART is a more complex and time consuming technique, but equally safe compared to RH in terms of oncological outcomes for selected women with early stage CC and allows for more CC survivors of childbearing age to preserve their fertility.
在美国,宫颈癌(CC)是生育年龄女性死亡的第二大原因。腹式根治性宫颈切除术(ART)是一种保留生育力的方法,已被提议用于希望保留生育力的早期 CC 女性。本荟萃分析的目的是评估 RH 与 ART 治疗早期 CC 的短期和长期结果。
共检索了 5 个电子数据库,以获取截至 2018 年 12 月发表的文章。纳入了报道接受 ART 或 RH 治疗早期 CC 女性的前瞻性和回顾性试验。使用 RevMan 5.3 软件进行统计荟萃分析。
共有 5 项研究纳入了 840 例接受 ART 或根治性宫颈切除术(RH)治疗的患者,其中 324 例接受了 ART,其余 516 例接受了 RH。尽管与 RH 相比,ART 手术时间明显延长(840 例患者 MD 36.82 分钟,95%CI 20.15-53.49,p<0.001),但两组 5 年 OS 和 5 年无病生存率无差异(714 例患者 OR 1.39,95%CI 0.53-3.62,p=0.51 和 682 例患者 OR 1.08,95%CI 0.52-2.25,p=0.84)。
ART 是一种更复杂且耗时的技术,但与 RH 相比,在选择的早期 CC 女性中具有相似的肿瘤学结果,并且能够让更多的生育年龄的 CC 幸存者保留生育能力。